Philogen
HealthcareBiotech & Pharma
HQ: Siena, Italy
Investors: 3 (1 current, 2 exited)
Innovative Swiss-Italian biotechnology company engaged in the research, development and manufacturing of biopharmaceutical products
Investors (3)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| The Equity Club | Current | - | - | Website |
| Algebris | Exited | - | - | - |
| Eurizon Real Asset | Exited | - | - | - |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get SignalsSignals (1)
ExitThe Equity Club
2026-02-12 (observed)Philogen IPO: final results of the institutional placement
Source: The Equity Club